Arrhythmogenic right ventricular cardiomyopathy (ARVC) causes ventricular arrhythmias (VAs) and sudden cardiac death (SCD). In 2019, a risk prediction model that estimates the 5-year risk of incident VAs in ARVC was developed (ARVCrisk.com). This study aimed to externally validate this prediction model in a large international multicentre cohort and to compare its performance with the risk factor approach recommended for implantable cardioverter-defibrillator (ICD) use by published guidelines and expert consensus.

Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator / Jordà, P., Bosman, L.P., Gasperetti, A., Mazzanti, A., Gourraud, J.B., Davies, B., Frederiksen, T.C., Moreno Weidmann, Z., Di Marco, A., Roberts, J.D., Macintyre, C., Seifer, C., Delinière, A., Alqarawi, W., Kukavica, D., Minois, D., Trancuccio, A., Arnaud, M., Targetti, M., Martino, A., et al.. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - 43:32(2022), pp. 3041-3052. [10.1093/eurheartj/ehac289]

Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator

Compagnucci, Paolo;Dello Russo, Antonio;Casella, Michela;
2022-01-01

Abstract

Arrhythmogenic right ventricular cardiomyopathy (ARVC) causes ventricular arrhythmias (VAs) and sudden cardiac death (SCD). In 2019, a risk prediction model that estimates the 5-year risk of incident VAs in ARVC was developed (ARVCrisk.com). This study aimed to externally validate this prediction model in a large international multicentre cohort and to compare its performance with the risk factor approach recommended for implantable cardioverter-defibrillator (ICD) use by published guidelines and expert consensus.
2022
Arrhythmogenic right ventricular cardiomyopathy; Genetic cardiomyopathies; Implantable cardioverter-defibrillator; Risk stratification; Sudden cardiac death; Ventricular arrhythmias
File in questo prodotto:
File Dimensione Formato  
Paloma_Arrhythmic-risk-prediction_VoR_2022.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza d'uso: Creative commons
Dimensione 1.51 MB
Formato Adobe PDF
1.51 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11566/305293
Citazioni
  • ???jsp.display-item.citation.pmc??? 35
  • Scopus 64
  • ???jsp.display-item.citation.isi??? 62
social impact